CoChat

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis

Open access
He, Xing-kang, Su, Ting-ting, Si, Jian-min, Sun, Lei-min · 2016 · Medicine

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

To systematically assess the effect of metformin on colorectal cancer (CRC) risk and mortality in type 2 diabetes mellitus (T2DM) patients. We conducted a systematic search of PubMed, Web of Science, and the Cochrane Library databases for relevant articles before August 2015. Two investigators identified and extracted data independently. We adopted adjusted estimates to calculate summary estimates with 95% confidence interval (CI) using either a fixed-effects or a random-effects model. Subgroup and sensitivity analyses were conducted to evaluate the robustness of the pooled results. The risk of publication bias was assessed by examining funnel plot asymmetry as well as Begg test and Egger test. Fifteen studies on CRC incidence and 6 studies on CRC survival were finally included in our meta-analysis. The pooled odds ratio (OR) of observational studies illustrated that a slight 10% reduction of CRC incidence was associated with metformin use (OR = 0.90, 95% CI: 0.85-0.96). Furthermore, the pooled hazard ratio (HR) revealed an improved survival outcome for metformin users in CRC patients compared to nonusers (HR = 0.68, 95% CI: 0.58-081). There was no publication bias across studies. Our meta-analysis demonstrated that metformin therapy could slightly reduce CRC incidence and moderately improve the survival outcomes in patients with T2DM. More prospective studies are warranted to certify this protective association.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000002749

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Flow diagram summarizing study identification and selection.
FIGURE 1 Flow diagram summarizing study identification and selection.CC BY · PubMed Central
FIGURE 2 Meta-analysis of the association between metformin use and colorectal cancer risk in patients with diabetes mellitus.
FIGURE 2 Meta-analysis of the association between metformin use and colorectal cancer risk in patients with diabetes mellitus.CC BY · PubMed Central
FIGURE 3 Funnel plot analysis to detect publication bias.
FIGURE 3 Funnel plot analysis to detect publication bias.CC BY · PubMed Central
FIGURE 4 Meta-analysis of the association between metformin use and all-cause mortality in patients with diabetes mellitus.
FIGURE 4 Meta-analysis of the association between metformin use and all-cause mortality in patients with diabetes mellitus.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Oliveria, 2008, Cancer incidence among patients treated with antidiabetic pharmacotherapy. Diabetes & Metabolic Syndrome, Clinical Research & Reviews, 2, 47

Cited by

See all 59

Metadata

Authors
He, X.-K., Su, T.-T., Si, J.-M., & Sun, L.-M.
Affiliations
Sir Run Run Shaw Hospital (CN)
Corresponding author
Sun, Lei-min
Venue
Medicine
Published
2016-02
Volume
95
Issue
7
Pages
e2749
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2285738189
Cited by
59
References
55
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 15 · 2016: 5
FWCI
0.90
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81302070, 81372623)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
metformin, colorectal cancer, type 2 diabetes, colorectal cancer incidence, colorectal cancer survival, chemoprevention, drug repurposing
MeSH terms
Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin, Colorectal Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis. https://app.cochat.ai/papers/10.1097/md.0000000000002749
The paper
He, X.-K., Su, T.-T., Si, J.-M., & Sun, L.-M. (2016). Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis. Medicine. https://doi.org/10.1097/md.0000000000002749

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.